[1] Smith GE, Kokmen E, O’Brien PC. Risk factors for nursing home
placement in a population-based dementia cohort. J Am Geriatr Soc
2000;48:519–25.
[2] Wilson RS, McCann JJ, Li Y, et al. Nursing home placement, day care
use, and cognitive decline in Alzheimer’s disease. Am J Psychiatry
2007;164:910–5.
[3] Cohen-Mansfield J, Marx MS, Rosenthal AS. Dementia and agitation in
nursing home residents: how are they related? Psychol Aging 1990;5:3–8.
Author contributions
Data curation: Kyosuke Yorozuya, Hideaki Hanaoka.
Yorozuya et al. Medicine (2020) 99:37
Medicine
[4] Fernández M, Gobartt AL, Balañá M. Behavioural symptoms in patients
with Alzheimer’s disease and their association with cognitive impairment. BMC Neurol 2010;10:1–9.
[5] Abrahamson K, Clark D, Perkins A, et al. Does cognitive impairment
influence quality of life among nursing home residents? Gerontologist
2012;52:632–40.
[6] Shimada H, Makizako H, Doi T, et al. Cognitive impairment and
disability in older Japanese adults. PLoS One 2016;11:e0158720.
[7] Kamiya M, Sakurai T, Ogama N, et al. Factors associated with increased
caregivers’ burden in several cognitive stages of Alzheimer’s disease.
Geriatr Gerontol Int 2014;14(Suppl 2):45–55.
[8] WHO [Internet]. Dementia. [Cited 19 September 2019]. Available from:
https://www.who.int/news-room/fact-sheets/detail/dementia.
[9] Rodríguez-Sánchez E, Mora-Simón S, Patino-Alonso MC, et al.
Prevalence of cognitive impairment in individuals aged over 65 in an
urban area: DERIVA study. BMC Neurol 2011;11:147.
[10] Kuang W, Gao M, Tian L, et al. Trends in the prevalence of cognitive
impairment in Chinese older adults: based on the Chinese longitudinal
healthy longevity survey cohorts from 1998 to 2014. Int Health
2020;00:1–10.
[11] Winblad B, Jones RW, Wirth Y, et al. Memantine in moderate to severe
Alzheimer’s disease: a meta-analysis of randomised clinical trials.
Dement Geriatr Cogn Disord 2007;24:20–7.
[12] Jelic V, Haglund A, Kowalski J, et al. Donepezil treatment of severe
Alzheimer’s disease in nursing home settings. A responder analysis.
Dement Geriatr Cogn Disord 2008;26:458–66.
[13] Loy C, Schneider L. Galantamine for Alzheimer’s disease and mild
cognitive impairment (review). Cochrane Database Syst Rev 2006;1:
CD001747.
[14] Raschetti R, Albanese E, Vanacore N, et al. Cholinesterase inhibitors in
mild cognitive impairment: a systematic review of randomised trials.
PLoS Med 2007;4:1818–28.
[15] Sadowsky CH, Galvin JE. Guidelines for the management of cognitive
and behavioral problems in dementia. J Am Board Fam Med
2012;25:350–66.
[16] Cooper C, Li R, Livingston G. A systematic review of treatments for mild
cognitive impairment. Br J Psychiatry 2013;203:255–64.
[17] Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention,
intervention, and care. Lancet 2017;390:2673–734.
[18] Graessel E, Stemmer R, Eichenseer B, et al. Non-pharmacological,
multicomponent group therapy in patients with degenerative dementia: a
12-month randomized, controlled trial. BMC Med 2011;9:1–1.
[19] Kurz AF, Leucht S, Lautenschlager NT. The clinical significance of
cognition-focused interventions for cognitively impaired older adults: a
systematic review of randomized controlled trials. Int Psychogeriatr
2011;23:1364–75.
[20] Woods B, Spector AE, Jones CA, et al. Reminiscence therapy for
dementia. Cochrane Database Syst Rev 2005;2:CD001120.
[21] Olazarán J, Reisberg B, Clare L, et al. Nonpharmacological therapies in
Alzheimer’s disease: a systematic review of efficacy. Dement Geriatr
Cogn Disord 2010;30:161–78.
[22] Vasionyte I, Madison G. Musical intervention for patients with
dementia: a meta-analysis. J Clin Nurs 2013;22:1203–16.
[23] Yorozuya K, Kubo Y, Tomiyama N, et al. A systematic review of
multimodal non-pharmacological interventions for cognitive function in
older people with dementia in nursing homes. Dement Geriatr Cogn
Disord 2019;48:1–6.
[24] Regier NG, Hodgson NA, Gitlin LN. Characteristics of activities for
persons with dementia at the mild, moderate, and severe stages.
Gerontologist 2017;57:987–97.
[25] Klapwijk MS, Caljouw MA, Pieper MJ, et al. Characteristics
associated with quality of life in long-term care residents with dementia:
a cross-sectional study. Dement Geriatr Cogn Disord 2016;42:
186–97.
[26] Gelman A. Bayesian Dara Analysis. Third Edition. Chapman and Hall/
CRC; 2013.
[27] Folstein MF, Folstein SE, McHugh PR. Mini-mental state”. A practical
method for grading the cognitive state of patients for the clinician. J
Psychiatr Res 1975;12:189–98.
[28] Sugishita M. Mini Mental State Examination-Japanese (MMSE-J). 2019;
Nihon Bunka Kagakusha Co., Ltd, PAR, Inc,
[29] Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the
staging of dementia. Br J Psychiatry 1982;140:566–72.
[30] Wiederman MW, Morgan CD. The neurobehavioral cognitive status
exam (NCSE) with geriatric inpatients. Clin Gerontologist 1995;15:
37–41.
[31] Matsuda O, Nakatani M. Manual for Japanese version of the
Neurobehavioral Cognitive Status Examination (COGNISTAT). Tokyo:
World Plan; 2004.
[32] Yamanaka K, Kawano Y, Noguchi D, et al. Effects of cognitive
stimulation therapy Japanese version (CST-J) for people with dementia: a
single-blind, controlled clinical trial. Aging Ment Health 2013;17:
579–86.
[33] Chalfont G, Milligan C, Simpson J. A mixed methods systematic review
of multimodal non-pharmacological interventions to improve cognition
for people with dementia. Dementia 2018;19:1–45.
[34] Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md
State Med J 1965;14:61–5.
[35] Kruschke JK. Bayesian estimation supersedes the t test. J Exp Psychol
Gen 2013;142:573–603.
[36] Kruschke JK. Doing Bayesian Data Analysis a Tutorial with R, JAGS,
and Stan Editon 2. Amsterdam, Boston, Heidelberg, London, New York,
Oxford, Paris, San Diego, San Francisco, Singapore, Sydney, Tokyo;
Academic Press is an imprint of Elsevier. 2015.
[37] Ozechowski TJ, Empirical Bayes MCMC. estimation for modeling
treatment processes, mechanisms of change, and clinical outcomes in
small samples. J Consult Clin Psychol 2014;82:854–67.
[38] Gelman A. Prior distributions for variance parameters in hierarchical
models (comment on article by Browne and Draper). Bayesian Anal
2006;1:515–33.
[39] Polson NG, Scott JG. On the half-cauchy prior for a global scale
parameter. Bayesian Anal 2012;7:887–902.
[40] Kyougoku M, Teraoka M. Bayesian analysis of the relationship between
belief conflict and occupational dysfunction. Am J Occup Ther
2019;73:7306205040p1-7306205040p9.
[41] Kawashima R. Mental exercises for cognitive function: clinical evidence.
J Prev Med Public Health 2013;46(Suppl 1):S22–7.
[42] Bahar-Fuchs A, Martyr A, Goh AM, et al. Cognitive training for people
with mild to moderate dementia. Cochrane Database Syst Rev 2019;3:
CD013069.
[43] Liang JH, Xu Y, Lin L, et al. Comparison of multiple interventions for
older adults with Alzheimer disease or mild cognitive impairment: a
PRISMA-compliant network meta-analysis. Medicine (Baltimore)
2018;97:e10744.
[44] Jia RX, Liang JH, Xu Y, et al. Effects of physical activity and exercise on
the cognitive function of patients with Alzheimer disease: a metaanalysis. BMC Geriatr 2019;19:181.
[45] de Souto Barreto P, Cesari M, Denormandie P, et al. Exercise or social
intervention for nursing home residents with dementia: a pilot
randomized, controlled trial. J Am Geriatr Soc 2017;65:E123–9.
...